... Oct 25
Cabaletta Bio, today announced that the first patient has been dosed in the DesCAARTesâ„¢ Phase 1 clinical trial of DSG3-CAART for the treatment of ... Dec 09
COVAXX will begin Phase I/II trials with the University of Nebraska Medical Center, home to the nation's only federal infectious disease quarantine center ... Jul 18
-Advertisements-